These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16270770)

  • 1. Helicobacter pylori eradication for the treatment of dyspeptic symptoms in chronic renal failure.
    Simunić M; Ljutić D; Mise S; Pesutić-Pisac V; Tonkić M; Hozo I
    Ann Saudi Med; 2005; 25(5):425-7. PubMed ID: 16270770
    [No Abstract]   [Full Text] [Related]  

  • 2. Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.
    Adamek RJ; Pfaffenbach B; Szymanski C
    Helicobacter; 1998 Sep; 3(3):206-11. PubMed ID: 9731993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection].
    Cui M; Hu F; Jiang H; Zheng X
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1245-8. PubMed ID: 12425803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients.
    Pilotto A; Leandro G; Franceschi M; Bierti L; Di Battista R; Notarbartolo A; Pisciotta G; Grassi A; Crestani B; Tafner G; Michelagnoli S; Garotta F
    Hepatogastroenterology; 1999; 46(25):245-51. PubMed ID: 10228801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
    Kyzekova J; Mour J
    Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of pantoprazole in the eradicating treatment of Helicobacter pylori].
    Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
    Rev Clin Esp; 1998 Oct; 198(10):678-83. PubMed ID: 9844458
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy.
    Eisig JN; André SB; Silva FM; Hashimoto C; Moraes-Filho JP; Laudanna AA
    Arq Gastroenterol; 2003; 40(1):55-60. PubMed ID: 14534667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia.
    Broutet N; Marais A; Lamouliatte H; de Mascarel A; Samoyeau R; Salamon R; Mégraud F
    J Clin Microbiol; 2001 Apr; 39(4):1319-22. PubMed ID: 11283049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
    Wong WM; Huang J; Xia HH; Fung FM; Tong TS; Cheung KL; Ho VY; Lai KC; Chan CK; Chan AO; Hui CK; Lam SK; Wong BC
    J Gastroenterol Hepatol; 2005 Jun; 20(6):935-40. PubMed ID: 15946144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group.
    Adamek RJ; Bethke TD
    Am J Gastroenterol; 1998 Oct; 93(10):1919-24. PubMed ID: 9772056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.
    de Boer SY; v d Meeberg PC; Siem H; de Boer WA
    Neth J Med; 2003 Jun; 61(6):218-22. PubMed ID: 12956102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing.
    Sivri B; Simsek I; Hulagu S; Kadayifci A; Tozun N; Akarsu M; Uraz S; Savas MC; Koruk M; Bozbas A
    Curr Med Res Opin; 2004 Aug; 20(8):1301-7. PubMed ID: 15324533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.
    Wu CJ; Hsu PI; Lo GH; Lo CC; Lin CK; Shie CB; Peng NJ; Tseng HH; Jou HS; Tsai PM; Chen A; Chen JL; Lai KH
    J Chin Med Assoc; 2004 Apr; 67(4):161-7. PubMed ID: 15244013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
    Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori: factors affecting eradication and recurrence.
    Vakil N
    Am J Gastroenterol; 2005 Nov; 100(11):2393-4. PubMed ID: 16279890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J; Farkkilä M; Sipponen P
    Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
    Pilotto A; Perri F; Leandro G; Franceschi M;
    Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial.
    Svoboda P; Kantorová I; Ochmann J; Doubek J; Kozumplík L; Marsová J
    Hepatogastroenterology; 1997; 44(15):886-90. PubMed ID: 9222709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In treatment of active duodenal ulcer and Helicobacter pylori eradication.
    Yukselen V; Yasa MH; Karaoglu AO
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cccvi-cccviii. PubMed ID: 15244210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.